Back

Inter-atrial block and atrial fibrillation predict cardiac adverse events in heart failure with preserved ejection fraction

25 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Heart failure outcomes: effects of phenotypes and comorbidities Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Helena Lopez Martinez

Houston Methodist DeBakey Heart & Vascular Center, Houston (United States of America)

6 More presentations in this session

Presentation thumbnail
Outcomes in patients admitted with diabetic ketoacidosis and heart failure with preserved ejection fraction
Unknown H. Alagbo (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Heart failure with mildly reduced ejection fraction is not all alike: the importance of disease trajectory
Doctor J. Ferreira (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction.
Mr J. Perea Armijo (Zaragoza, ES)
Abstract Slides Video
Presentation thumbnail
Worse long term prognosis in new onset HFpEF treated in HF clinics compared to HFrEF and HFmrEF patients; reflecting need for effective treatment in HFpEF. Results from the Stockholm PREFERS Study.
Doctor M. Ekstrom (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue is associated with an increased risk of mortality and hospitalizations in patients with heart failure with preserved ejection fraction
Doctor M. Grubler (Wiener Neustadt, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure outcomes: effects of phenotypes and comorbidities

The Event

Event poster

ESC Congress 2023

25 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF
thumbnail
Congress Presentation
Heart failure with preserved ejection fraction and incidence rate of atrial fibrillation: insights from a randomized clinical trial
thumbnail
Congress Presentation
Characterising the role of atrial fibrillation in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources